Clinical Trial Update: Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating imetelstat in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia after failure of hypomethylating agent therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Imetelstat (imetelstat)

Snippet

Sponsor: GCP-Service International West GmbH | Conditions: Myelodysplastic Syndromes, Acute Myeloid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING